Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
DHANUKA.NS Stock Summary
Top 10 Correlated ETFs
DHANUKA.NS
In the News
DHANUKA.NS Financial details
Company Rating
Buy
Market Cap
43.69B
Income
2.45B
Revenue
17.61B
Book val./share
-
Cash/share
-
Dividend
2
Dividend %
0.16%
Employees
1.04K
Optionable
No
Shortable
Yes
Earnings
22 Apr 2024
P/E
22.55
Forward P/E
16.18
PEG
11.36
P/S
3.17
P/B
4.68
P/C
-
P/FCF
-
Quick Ratio
1.89
Current Ratio
2.94
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
53.75
EPS next Y
63.41
EPS next Q
-
EPS this Y
12.26%
EPS next Y
17.96%
EPS next 5Y
35.85%
EPS last 5Y
16.94%
Revenue last 5Y
11.22%
Revenue Q/Q
-34.74%
EPS Q/Q
-55.44%
-
-
-
-
SMA20
-14.37%
SMA50
-20.7%
SMA100
21.52%
Inst Own
-
Inst Trans
-
ROA
15%
ROE
44%
ROC
0.26%
Gross Margin
37%
Oper. Margin
18%
Profit Margin
14%
Payout
-
Shs Outstand
45.58M
Shs Float
12.59M
-
-
-
-
Target Price
-
52W Range
605.1-1298.0
52W High
-20.97%
52W Low
+69.56%
RSI
50
Rel Volume
0.81
Avg Volume
71.54K
Volume
58K
Perf Week
5.62%
Perf Month
-1.93%
Perf Quarter
21.7%
Perf Half Y
20.1%
-
-
-
-
Beta
0.883
-
-
Volatility
29.47%, 70.15%
Prev Close
0.94%
Price
1025.85
Change
7.1%
DHANUKA.NS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 204.32 | 233.37 | 291.02 | 314.15 | 366.62 | |
Net income per share | 23.02 | 29.71 | 44.61 | 44.85 | 50.35 | |
Operating cash flow per share | 0.89 | 34.07 | 48.96 | 22.39 | 29.37 | |
Free cash flow per share | -0.36 | 31.18 | 46.28 | 9.54 | 2.6 | |
Cash per share | 6.33 | 17.85 | 39.89 | 42.41 | 36.01 | |
Book value per share | 131.33 | 148.72 | 168.69 | 206.19 | 228.85 | |
Tangible book value per share | 130.81 | 148.23 | 168.28 | 205.86 | 228.59 | |
Share holders equity per share | 131.33 | 148.72 | 168.69 | 206.19 | 228.85 | |
Interest debt per share | 4.72 | 3.03 | 10.83 | 7.52 | 7.9 | |
Market cap | 19.55B | 15.47B | 32.55B | 33.43B | 28.35B | |
Enterprise value | 19.77B | 15.35B | 33.03B | 33.73B | 28.65B | |
P/E ratio | 17.37 | 10.95 | 15.46 | 16 | 12.14 | |
Price to sales ratio | 1.96 | 1.39 | 2.37 | 2.28 | 1.67 | |
POCF ratio | 450.78 | 9.55 | 14.09 | 32.06 | 20.81 | |
PFCF ratio | -1.13K | 10.43 | 14.9 | 75.21 | 235.31 | |
P/B Ratio | 3.04 | 2.19 | 4.09 | 3.48 | 2.67 | |
PTB ratio | 3.04 | 2.19 | 4.09 | 3.48 | 2.67 | |
EV to sales | 1.98 | 1.38 | 2.4 | 2.31 | 1.69 | |
Enterprise value over EBITDA | 12.29 | 7.92 | 11.47 | 11.9 | 8.86 | |
EV to operating cash flow | 455.79 | 9.47 | 14.29 | 32.35 | 21.03 | |
EV to free cash flow | -1.14K | 10.35 | 15.12 | 75.89 | 237.81 | |
Earnings yield | 0.06 | 0.09 | 0.06 | 0.06 | 0.08 | |
Free cash flow yield | 0 | 0.1 | 0.07 | 0.01 | 0 | |
Debt to equity | 0.03 | 0.02 | 0.06 | 0.03 | 0.03 | |
Debt to assets | 0.03 | 0.01 | 0.04 | 0.02 | 0.02 | |
Net debt to EBITDA | 0.14 | -0.06 | 0.17 | 0.11 | 0.09 | |
Current ratio | 3.64 | 3.37 | 3.11 | 3.14 | 3.01 | |
Interest coverage | 149.84 | 101.28 | 94.26 | 77.68 | 85.77 | |
Income quality | 0.03 | 0.9 | 0.81 | 0.38 | 0.45 | |
Dividend Yield | 0.01 | 0.04 | 0.01 | 0.01 | 0.01 | |
Payout ratio | 0.15 | 0.42 | 0.11 | 0.22 | 0.12 | |
Sales general and administrative to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | -1.4 | -0.08 | -0.05 | -0.57 | -0.91 | |
Capex to revenue | -0.01 | -0.01 | -0.01 | -0.04 | -0.07 | |
Capex to depreciation | -0.49 | -0.84 | -0.83 | -3.68 | -7.05 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 260.82 | 315.29 | 411.5 | 456.14 | 509.17 | |
ROIC | 0.15 | 0.17 | 0.21 | 0.18 | 0.18 | |
Return on tangible assets | 0.14 | 0.15 | 0.19 | 0.16 | 0.17 | |
Graham Net | 42.64 | 49.17 | 59.76 | 70.17 | 53.95 | |
Working capital | 4.31B | 4.69B | 5.82B | 6.5B | 5.98B | |
Tangible asset value | 6.4B | 7.05B | 7.94B | 9.59B | 10.6B | |
Net current asset value | 4.01B | 4.42B | 5.23B | 6.03B | 5.52B | |
Invested capital | 0.03 | 0.02 | 0.06 | 0.03 | 0.03 | |
Average receivables | 1.78B | 3.44B | 3.53B | 3.92B | 3.75B | |
Average payables | 802.69M | 953.71M | 1.11B | 1.42B | 1.75B | |
Average inventory | 2.06B | 2.28B | 2.73B | 3.21B | 3.46B | |
Days sales outstanding | 130.17 | 109 | 99.51 | 102.26 | 72.89 | |
Days payables outstanding | 45.81 | 58 | 45.86 | 67.83 | 57.34 | |
Days of inventory on hand | 122.2 | 128 | 124.77 | 134.79 | 112.91 | |
Receivables turnover | 2.8 | 3.35 | 3.67 | 3.57 | 5.01 | |
Payables turnover | 7.97 | 6.29 | 7.96 | 5.38 | 6.37 | |
Inventory turnover | 2.99 | 2.85 | 2.93 | 2.71 | 3.23 | |
ROE | 0.18 | 0.2 | 0.26 | 0.22 | 0.22 | |
Capex per share | -1.24 | -2.88 | -2.67 | -12.84 | -26.78 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q3
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 84.45 | 81.12 | 81.01 | 135.58 | 88.47 | |
Net income per share | 9.89 | 14.27 | 7.23 | 22.33 | 9.95 | |
Operating cash flow per share | 1.91 | 2.23 | 2.03 | 4.34 | 5.65 | |
Free cash flow per share | 1.91 | 2.23 | 2.03 | 4.34 | 5.65 | |
Cash per share | 7.55 | 36.49 | 21.79 | 33.97 | 0 | |
Book value per share | 226.48 | 231.91 | 232.95 | 260.43 | 0 | |
Tangible book value per share | 0 | 231.65 | 0 | 260.18 | 0 | |
Share holders equity per share | 226.48 | 231.91 | 232.95 | 260.43 | 0 | |
Interest debt per share | 0.17 | 7.49 | 0.2 | 7.08 | 0.16 | |
Market cap | 33.2B | 27.98B | 36.45B | 38.36B | 49.35B | |
Enterprise value | 33.55B | 28.28B | 37.44B | 38.65B | 49.35B | |
P/E ratio | 18.02 | 10.71 | 27.66 | 9.42 | 27.2 | |
Price to sales ratio | 8.44 | 7.54 | 9.87 | 6.21 | 12.24 | |
POCF ratio | 372.57 | 274.15 | 394.02 | 194.06 | 191.59 | |
PFCF ratio | 372.57 | 274.15 | 394.02 | 194.06 | 191.59 | |
P/B Ratio | 3.15 | 2.64 | 3.43 | 3.23 | 0 | |
PTB ratio | 3.15 | 2.64 | 3.43 | 3.23 | 0 | |
EV to sales | 8.53 | 7.62 | 10.14 | 6.26 | 12.24 | |
Enterprise value over EBITDA | 56.4 | 30.54 | 74.5 | 26.23 | 71.07 | |
EV to operating cash flow | 376.51 | 277.09 | 404.75 | 195.57 | 191.59 | |
EV to free cash flow | 376.51 | 277.09 | 404.75 | 195.57 | 191.59 | |
Earnings yield | 0.01 | 0.02 | 0.01 | 0.03 | 0.01 | |
Free cash flow yield | 0 | 0 | 0 | 0.01 | 0.01 | |
Debt to equity | 0 | 0.03 | 0 | 0.03 | 0 | |
Debt to assets | 0 | 0.02 | 0 | 0.02 | 0 | |
Net debt to EBITDA | 0.59 | 0.32 | 1.98 | 0.2 | 0 | |
Current ratio | 0 | 3.01 | 0 | 2.94 | 0 | |
Interest coverage | 71.2 | 114.39 | 43.72 | 181.46 | 76.87 | |
Income quality | 0.19 | 0.16 | 0.28 | 0.19 | 0.57 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0.06 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0.01 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 224.49 | 272.87 | 194.67 | 361.72 | 0 | |
ROIC | 0.04 | 0.06 | 0.03 | 0.08 | 0 | |
Return on tangible assets | 0 | 0.05 | 0 | 0.06 | 0 | |
Graham Net | 7.55 | 54.67 | 21.79 | 69.45 | 0 | |
Working capital | 351.87M | 5.98B | 992.53M | 7.17B | 0 | |
Tangible asset value | 0 | 10.6B | 0 | 11.86B | 0 | |
Net current asset value | 351.87M | 5.52B | 992.53M | 6.72B | 0 | |
Invested capital | 0 | 0.03 | 0 | 0.03 | 0 | |
Average receivables | 2.36B | 1.7B | 1.7B | 2.73B | 2.73B | |
Average payables | 817.13M | 876.17M | 876.17M | 763.13M | 763.13M | |
Average inventory | 1.88B | 1.73B | 1.73B | 1.68B | 1.68B | |
Days sales outstanding | 0 | 82.31 | 0 | 79.39 | 0 | |
Days payables outstanding | 0 | 68.73 | 0 | 37.23 | 0 | |
Days of inventory on hand | 0 | 135.33 | 0 | 81.77 | 0 | |
Receivables turnover | 0 | 1.09 | 0 | 1.13 | 0 | |
Payables turnover | 0 | 1.31 | 0 | 2.42 | 0 | |
Inventory turnover | 0 | 0.67 | 0 | 1.1 | 0 | |
ROE | 0.04 | 0.06 | 0.03 | 0.09 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
DHANUKA.NS Frequently Asked Questions
What is Dhanuka Agritech Limited stock symbol ?
Dhanuka Agritech Limited is a IN stock and trading under the symbol DHANUKA.NS
What is Dhanuka Agritech Limited stock quote today ?
Dhanuka Agritech Limited stock price is $1025.85 today.
Is Dhanuka Agritech Limited stock public?
Yes, Dhanuka Agritech Limited is a publicly traded company.